The UK announced the funding at the AI Action Summit in Paris where it abstained from signing a declaration on an inclusive ...

The World Health Organization and St Jude Children's Research Hospital have kicked off a programme to distribute cancer ...

Grace has announced the initial closing of a financing round, securing almost $15m, for funding pre-commercial development of ...

Eli Lilly is paying up to $630m for a Phase I MASH candidate from OliX Pharmaceuticals, diversifying its pipeline with an RNA ...

Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease ...

Novartis has agreed to acquire Anthos Therapeutics, a Boston-based clinical-stage biopharmaceutical company, for an upfront ...

Deals, pipeline updates and geopolitical issues drove the conversation at the 2025 JP Morgan Healthcare conference.

Nerandomilast is posed to be Boehringer Ingelheim’s successor to its blockbuster Ofev (nintedanib)in IPF and PPF.